glp-1 management digital health startups private companies obesity A whole person view of obesity care: Staying competitive in an evolving market Inside CVS Ventures' $25M Bet

Leone-Bay A, Grant M, Greene S, Stowell G, Daniels S, Smithson A, et al

Some patients aren't candidates for weight loss surgery, while others simply want medical weight loss options that don't jump straight to surgery

Using Inovalons MORE 2 Registry , the largest primary source patient dataset, and advanced analytic solutions, we examined patient and provider characteristics associated with off-label usage

Although around 12 percent of Americans say they have taken a GLP-1 at one time or another, the long-term effects of using these drugs as well as the health impacts of discontinuing use are not well known

There are also GLP-1 medications produced by compounding pharmacies, which use tirzepatide, semaglutide, or another GLP-1 receptor agonist